Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 8Sanofi
02 1Biocon
03 1Biocon Biologics
04 2Biosimilar Collaborations Ireland Limited
05 88Novo Nordisk
01 4CAT
02 1Flextouch Injectable Solution In Pre-Filled Pen
03 1INJ
04 10INJECTABLE;SUBCUTANEOUS
05 1INJECTION;SOLUTION
06 9Injectable Solution
07 1Injectable Solution In A Pre-Filled Pen
08 2Injectable Solution In Cartridge
09 1Injectable Solution In Pre-Filled Pen
10 2Injectable Solution In Vial
11 1Injection fluid, resolution
12 1Injection fluid, resolution in sylinderampulle
13 1Injection fluid, resolution in the finished filled pen
14 1Injection fluid, resolution in the hood glass
15 2Injection fluid, suspension
16 1Insulin Aspart 160U 1,6Ml 5 Units Parenteral Use
17 2Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use
18 3PED
19 2PFP
20 1Penfill Injectable Solution In Cartridge
21 1Pumpcart Injectable Solution In Cartridge
22 9SOLUTION
23 1SOLUTION;INTRAVENOUS, SUBCUTANEOUS
24 3SOLUTION;SUBCUTANEOUS
25 2SUSPENSION
26 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 30/70 300Iu 3Ml 5 Units Parenteral Use
27 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 50/50 300Iu 3Ml 5 Units Parenteral Use
28 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 70/30 300Iu 3Ml 5 Units Parenteral Use
29 25Solution For Injection
30 5Suspension For Injection
31 4Blank
01 11Allowed
02 22Approved
03 9Authorized
04 6Deregistered
05 10Originator
06 11Schedule D
07 31Blank
01 4FIASP
02 1FIASP FLEXTOUCH
03 1FIASP PENFILL
04 9Fiasp
05 1Fiasp Eml ultra-fast-acting PumpCart
06 1Fiasp Penfill
07 1Fiasp Pumpcart
08 1Fiasp ultra-fast-acting
09 1Fiasp ultra-fast-acting FlexTouch
10 1Fiasp ultra-fast-acting Penfill
11 3Insulin Aspart Sanofi
12 1Insulin NovoNordisk NovoRapid
13 1Insulin NovoNordisk NovoRapid FlexPen
14 1Insulin NovoNordisk NovoRapid FlexTouch
15 1Insulin NovoNordisk NovoRapid Penfill
16 1Insulin NovoNordisk NovoRapid PumpCart Eml
17 2KIRSTY
18 2Kirsty
19 1NOVOLOG
20 1NOVOLOG FLEXPEN
21 1NOVOLOG FLEXTOUCH
22 1NOVOLOG INNOLET
23 1NOVOLOG MIX 50/50
24 1NOVOLOG MIX 70/30
25 1NOVOLOG MIX 70/30 FLEXPEN
26 2NOVOLOG MIX 70/30 PENFILL
27 1NOVOLOG PENFILL
28 2NOVOMIX 30
29 2NOVORAPID
30 1Novo rapid
31 1Novo rapid Flexpen
32 1Novo rapid Penfill
33 1Novo rapid pump the cart
34 2NovoMix 30
35 4NovoRapid
36 1NovoRapid FlexPen
37 1NovoRapid Penfill 3 mL
38 3Novomix
39 1Novomix 30 Flexpen
40 1Novomix 30 Novolet
41 1Novomix 30 Penfill
42 1Novomix 30 Penfill 100 E/ml
43 1Novomix 50 Flexpen
44 1Novomix 50 Penfill
45 1Novomix 70 Flexpen
46 1Novomix 70 Penfill
47 1Novomix Flexpen 30 100 E/ml
48 3Novorapid
49 3Novorapid Flexpen
50 1Novorapid Flextouch
51 1Novorapid Innolet
52 1Novorapid Novolet
53 2Novorapid Penfill
54 2Novorapid Pumpcart
55 1Novorapidfill
56 1RYZODEG 70/30
57 1Ryzodeg
58 1Ryzodeg FlexTouch
59 1Ryzodeg Flexpen
60 1Ryzodeg Flextouch
61 2Ryzodeg Penfill
62 3Ryzodeg®
63 3TRURAPI
64 2Truvelog Mix 30
01 4Australia
02 11Canada
03 6Italy
04 6Norway
05 10South Africa
06 9Spain
07 28Sweden
08 11Switzerland
09 15USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Injectable Solution
Dosage Strength : 100E/ml
Packaging :
Approval Date : 21/04/2021
Application Number : 20200727000046
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Solution For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/06/2020
Application Number : 20190604000057
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Solution For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/06/2020
Application Number : 20190604000064
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Insulin Aspart (Soluble); Insulin Aspart Protamine
Brand Name : Truvelog Mix 30
Dosage Form : Suspension For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/04/2022
Application Number : 20210429000121
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Insulin Aspart (Soluble); Insulin Aspart Protamine
Brand Name : Truvelog Mix 30
Dosage Form : Injectable Solution
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/04/2022
Application Number : 20210429000114
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506564
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506572
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2529254
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG INNOLET
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXTOUCH
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 70/30 FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML)
Packaging :
Approval Date :
Application Number : 21172
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
Brand Name : NOVOLOG MIX 50/50
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 50 UNITS/ML;50 UNITS/ML
Packaging :
Approval Date :
Application Number : 21810
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
INSULIN ASPART; INSULIN DEGLUDEC
Brand Name : RYZODEG 70/30
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 90 UNITS/3ML;210 UNITS/3ML (30 UNITS/ML;70 UNITS/ML)
Packaging :
Approval Date :
Application Number : 203313
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FIASP
Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 208751
Regulatory Info :
Registration Country : USA
